UBS Group’s Regencell Bioscience RGC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $639K | Buy |
+37,527
| New | +$639K | ﹤0.01% | 4665 |
|
|
2025
Q1 | – | Sell |
-1,110,284
| Closed | -$144K | – | 9188 |
|
|
2024
Q4 | $144K | Buy |
1,110,284
+430,996
| +63% | +$56K | ﹤0.01% | 5453 |
|
|
2024
Q3 | $99.1K | Buy |
679,288
+667,432
| +5,629% | +$97.4K | ﹤0.01% | 5191 |
|
|
2024
Q2 | $1.05K | Sell |
11,856
-41,344
| -78% | -$3.66K | ﹤0.01% | 7510 |
|
|
2024
Q1 | $6.3K | Sell |
53,200
-556,814
| -91% | -$65.9K | ﹤0.01% | 6299 |
|
|
2023
Q4 | $169K | Buy |
+610,014
| New | +$169K | ﹤0.01% | 4700 |
|
|
2023
Q2 | – | Sell |
-38
| Closed | -$26 | – | 8307 |
|
|
2023
Q1 | $26 | Sell |
38
-25,384
| -100% | -$17.4K | ﹤0.01% | 8298 |
|
|
2022
Q4 | $18.2K | Buy |
25,422
+4,598
| +22% | +$3.29K | ﹤0.01% | 6576 |
|
|
2022
Q3 | $17K | Sell |
20,824
-6,650
| -24% | -$5.43K | ﹤0.01% | 6518 |
|
|
2022
Q2 | $25K | Buy |
27,474
+18,202
| +196% | +$16.6K | ﹤0.01% | 5579 |
|
|
2022
Q1 | $5K | Buy |
9,272
+1,976
| +27% | +$1.07K | ﹤0.01% | 8100 |
|
|
2021
Q4 | $6K | Buy |
+7,296
| New | +$6K | ﹤0.01% | 8165 |
|